Health Economics and Outcomes Research Services Market Size, Share, Trends, Growth Outlook

Health Economics and Outcomes Research Services Market is estimated to increase at a Compounded Annual Growth Rate of 10.9% CAGR over the forecast period from 2024 to 2030

The Health Economics and Outcomes Research Services Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments- By Service (Economic Modelling/Evaluation, Real-World Data Analysis and Information Systems, Clinical Outcome, Market Access Solutions and Reimbursement), By Service Provider (Consultancy, Contract Research Organizations (CROs)), By End-User (Biotech/Pharma Companies, Healthcare Providers, Government Organizations, Healthcare Payers).

An Introduction to Health Economics and Outcomes Research Services Market in 2024

Health economics and outcomes research (HEOR) services play a critical role in evaluating the economic and clinical value of healthcare interventions, informing healthcare decision-making, and optimizing resource allocation in the healthcare sector. In 2024, the market for HEOR services is characterized by a growing demand for evidence-based assessments of healthcare technologies, pharmaceuticals, and healthcare delivery models in diverse therapeutic areas and healthcare settings. HEOR methodologies, including cost-effectiveness analysis, budget impact modeling, and patient-reported outcomes research, provide stakeholders with valuable insights into the comparative effectiveness, cost implications, and societal impact of healthcare interventions. Additionally, advancements in real-world data analytics, predictive modeling, and health technology assessment (HTA) frameworks enhance the rigor and relevance of HEOR studies, supporting market access strategies, reimbursement decisions, and health policy formulation. As healthcare systems grapple with rising costs, limited resources, and the need for value-based care, HEOR services serve as indispensable tools for demonstrating the value proposition of healthcare innovations and ensuring optimal allocation of healthcare resources to improve patient outcomes and population health.

Market Trend: Increasing Emphasis on Value-Based Healthcare

A significant trend in the market for health economics and outcomes research (HEOR) services is the increasing emphasis on value-based healthcare. With healthcare systems worldwide facing mounting pressure to improve patient outcomes, optimize resource utilization, and contain costs, there's a notable shift towards value-based reimbursement models and evidence-based decision-making. Health economics and outcomes research play a pivotal role in evaluating the clinical and economic value of healthcare interventions, pharmaceutical products, and medical technologies by assessing their impact on patient outcomes, quality of life, and healthcare resource utilization. This trend reflects the growing recognition of the importance of HEOR insights in informing healthcare policies, reimbursement strategies, and treatment decisions to maximize value and achieve sustainable healthcare outcomes.

Market Driver: Demand for Evidence-Based Medicine and Health Technology Assessment

The primary driver propelling the market for health economics and outcomes research services is the demand for evidence-based medicine and health technology assessment (HTA). As healthcare stakeholders seek to make informed decisions about the allocation of resources, adoption of new technologies, and reimbursement of healthcare interventions, there's an increasing need for robust evidence on the clinical effectiveness, cost-effectiveness, and real-world outcomes of healthcare products and services. HEOR studies provide critical evidence to support HTA submissions, regulatory approvals, formulary decisions, and coverage determinations, helping healthcare decision-makers assess the value proposition of interventions and allocate resources efficiently. The growing reliance on evidence-based approaches to healthcare decision-making drives the demand for HEOR services as essential tools for evaluating the clinical, economic, and humanistic outcomes of healthcare interventions across various therapeutic areas and healthcare settings.

Market Opportunity: Integration of Real-World Data and Advanced Analytics

An untapped opportunity within the market for health economics and outcomes research services lies in the integration of real-world data (RWD) and advanced analytics methodologies. While randomized controlled trials (RCTs) remain the gold standard for generating clinical evidence, there's increasing recognition of the complementary role of RWD in providing insights into the effectiveness, safety, and economic impact of healthcare interventions in real-world clinical practice. By leveraging RWD sources such as electronic health records (EHRs), claims data, patient registries, and wearables, along with advanced analytics techniques such as machine learning, natural language processing, and predictive modeling, HEOR researchers can generate real-world evidence (RWE) that informs healthcare decision-making and improves patient outcomes. Integrating RWD and advanced analytics into HEOR studies offers opportunities to enhance the robustness, generalizability, and timeliness of evidence generation, supporting value-based healthcare initiatives and facilitating evidence-driven healthcare decision-making. Embracing the opportunity to integrate RWD and advanced analytics aligns to advance HEOR methodologies, generating actionable insights, and driving evidence-based healthcare innovation in the era of value-based medicine.

Health Economics and Outcomes Research (HEOR) Services Market Share Analysis: Real-World Data Analysis and Information Systems

In the Health Economics and Outcomes Research (HEOR) Services market, the Real-World Data Analysis and Information Systems segment is experiencing the most rapid growth. Real-world data (RWD) analysis plays a crucial role in assessing the effectiveness, safety, and economic impact of healthcare interventions in real-world clinical practice settings. With the increasing availability of electronic health records (EHRs), claims data, and other sources of real-world data, there is growing demand for services that leverage these data assets to generate insights into healthcare outcomes, treatment patterns, and healthcare utilization. Real-world evidence (RWE) derived from such analyses is essential for informing healthcare decision-making, including clinical trial design, market access strategies, and reimbursement decisions. Additionally, advancements in information systems and analytical tools enable more efficient and comprehensive analysis of real-world data, driving further demand for services in this segment. As stakeholders across the healthcare ecosystem increasingly recognize the value of real-world evidence in demonstrating product value and optimizing healthcare delivery, the Real-World Data Analysis and Information Systems segment is poised for continued rapid growth. Consequently, service providers specializing in this area are well-positioned to capitalize on emerging opportunities in the HEOR Services market.

Health Economics and Outcomes Research Services Competitive Analysis

The market research study provides in-depth insights into leading companies including the SWOT analyses, product profile, financial details, and recent developments acrossAnalysis Group Inc, Avalon Health Economics LLC, Axtria Inc, Cardinal Health Inc, ICON plc, McKesson Corp, MEDLIOR Inc, PHARMALEX GmbH, Syneos Health Inc, Thermo Fisher Scientific Inc, UnitedHealth Group Inc

Health Economics and Outcomes Research Services Market Segmentation

By Service
Economic Modelling/Evaluation
Real-World Data Analysis and Information Systems
Clinical Outcome
Market Access Solutions and Reimbursement
By Service Provider
Consultancy
Contract Research Organizations (CROs)
By End-User
Biotech/Pharma Companies
Healthcare Providers
Government Organizations
Healthcare Payers
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

Health Economics and Outcomes Research Services Market Companies

Analysis Group Inc
Avalon Health Economics LLC
Axtria Inc
Cardinal Health Inc
ICON plc
McKesson Corp
MEDLIOR Inc
PHARMALEX GmbH
Syneos Health Inc
Thermo Fisher Scientific Inc
UnitedHealth Group Inc

Reasons to Buy the Health Economics and Outcomes Research Services Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Health Economics and Outcomes Research Services Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Health Economics and Outcomes Research Services Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

1 Introduction to 2024 Health Economics and Outcomes Research Services Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Covered
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Health Economics and Outcomes Research Services Market Size Outlook, $ Million, 2021 to 2030
3.2 Health Economics and Outcomes Research Services Market Outlook by Type, $ Million, 2021 to 2030
3.3 Health Economics and Outcomes Research Services Market Outlook by Product, $ Million, 2021 to 2030
3.4 Health Economics and Outcomes Research Services Market Outlook by Application, $ Million, 2021 to 2030
3.5 Health Economics and Outcomes Research Services Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Health Economics and Outcomes Research Services Industry
4.2 Key Market Trends in Health Economics and Outcomes Research Services Industry
4.3 Potential Opportunities in Health Economics and Outcomes Research Services Industry
4.4 Key Challenges in Health Economics and Outcomes Research Services Industry

5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Health Economics and Outcomes Research Services Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Health Economics and Outcomes Research Services Market Outlook by Segments
7.1 Health Economics and Outcomes Research Services Market Outlook by Segments, $ Million, 2021- 2030
By Service
Economic Modelling/Evaluation
Real-World Data Analysis and Information Systems
Clinical Outcome
Market Access Solutions and Reimbursement
By Service Provider
Consultancy
Contract Research Organizations (CROs)
By End-User
Biotech/Pharma Companies
Healthcare Providers
Government Organizations
Healthcare Payers

8 North America Health Economics and Outcomes Research Services Market Analysis and Outlook To 2030
8.1 Introduction to North America Health Economics and Outcomes Research Services Markets in 2024
8.2 North America Health Economics and Outcomes Research Services Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Health Economics and Outcomes Research Services Market size Outlook by Segments, 2021-2030
By Service
Economic Modelling/Evaluation
Real-World Data Analysis and Information Systems
Clinical Outcome
Market Access Solutions and Reimbursement
By Service Provider
Consultancy
Contract Research Organizations (CROs)
By End-User
Biotech/Pharma Companies
Healthcare Providers
Government Organizations
Healthcare Payers

9 Europe Health Economics and Outcomes Research Services Market Analysis and Outlook To 2030
9.1 Introduction to Europe Health Economics and Outcomes Research Services Markets in 2024
9.2 Europe Health Economics and Outcomes Research Services Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Health Economics and Outcomes Research Services Market Size Outlook by Segments, 2021-2030
By Service
Economic Modelling/Evaluation
Real-World Data Analysis and Information Systems
Clinical Outcome
Market Access Solutions and Reimbursement
By Service Provider
Consultancy
Contract Research Organizations (CROs)
By End-User
Biotech/Pharma Companies
Healthcare Providers
Government Organizations
Healthcare Payers

10 Asia Pacific Health Economics and Outcomes Research Services Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Health Economics and Outcomes Research Services Markets in 2024
10.2 Asia Pacific Health Economics and Outcomes Research Services Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Health Economics and Outcomes Research Services Market size Outlook by Segments, 2021-2030
By Service
Economic Modelling/Evaluation
Real-World Data Analysis and Information Systems
Clinical Outcome
Market Access Solutions and Reimbursement
By Service Provider
Consultancy
Contract Research Organizations (CROs)
By End-User
Biotech/Pharma Companies
Healthcare Providers
Government Organizations
Healthcare Payers

11 South America Health Economics and Outcomes Research Services Market Analysis and Outlook To 2030
11.1 Introduction to South America Health Economics and Outcomes Research Services Markets in 2024
11.2 South America Health Economics and Outcomes Research Services Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Health Economics and Outcomes Research Services Market size Outlook by Segments, 2021-2030
By Service
Economic Modelling/Evaluation
Real-World Data Analysis and Information Systems
Clinical Outcome
Market Access Solutions and Reimbursement
By Service Provider
Consultancy
Contract Research Organizations (CROs)
By End-User
Biotech/Pharma Companies
Healthcare Providers
Government Organizations
Healthcare Payers
12 Middle East and Africa Health Economics and Outcomes Research Services Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Health Economics and Outcomes Research Services Markets in 2024
12.2 Middle East and Africa Health Economics and Outcomes Research Services Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Health Economics and Outcomes Research Services Market size Outlook by Segments, 2021-2030
By Service
Economic Modelling/Evaluation
Real-World Data Analysis and Information Systems
Clinical Outcome
Market Access Solutions and Reimbursement
By Service Provider
Consultancy
Contract Research Organizations (CROs)
By End-User
Biotech/Pharma Companies
Healthcare Providers
Government Organizations
Healthcare Payers

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Analysis Group Inc
Avalon Health Economics LLC
Axtria Inc
Cardinal Health Inc
ICON plc
McKesson Corp
MEDLIOR Inc
PHARMALEX GmbH
Syneos Health Inc
Thermo Fisher Scientific Inc
UnitedHealth Group Inc

14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Service
Economic Modelling/Evaluation
Real-World Data Analysis and Information Systems
Clinical Outcome
Market Access Solutions and Reimbursement
By Service Provider
Consultancy
Contract Research Organizations (CROs)
By End-User
Biotech/Pharma Companies
Healthcare Providers
Government Organizations
Healthcare Payers
Countries Analyzed
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)